Brugada-Phenocopy Induced by Propafenone Overdose and Successful
Treatment: A Case Report Brugada syndrome is an inherited arrhythmogenic disease that may cause sudden cardiac death due to ventricular fibrillation in young adults. Brugada syndrome is usually identified by a characteristic type 1 electrocardiography (ECG) pattern that consists of ST elevation of a coved type in the precordial leads V 1 to V 3 . In addition, the term Brugada phenocopy is used to describe conditions that induce Brugada-like ECG manifestations in patients without true Brugada syndrome. Some drugs and conditions can cause a Brugada type 1 ECG pattern which is not true congenital Brugada syndrome (1, 2) . Propafenone (Rythmol, Abbott, Chicago, IL, USA) is a group 1C antiarrhythmic drug that has sodium channel-blocking effects. Excessive intake may cause severe arrhythmias such as bradycardia, sinoatrial block, atrioventricular block, intraventricular block, junctional and/or ventricular tachycardia, or chaotic ventricular rhythm (3) (4) (5) (6) (7) . Intoxication with class I antiarrhythmic drugs is associated with a higher mortality rate (22.5%) than other drugs (1%) (3). We present a case report of successful treatment of Brugada phenocopy due to propafenone intoxication.
CASE PRESENTATION
A 15-year-old girl was admitted to the emergency room with complaints of vomiting and loss of consciousness lasting 3 hours. Upon admission, her blood pressure was 70/45 mmHg, her heart rate was 60/minute, and the body temperature was 36. Figure  1 ). Haemodynamic and neurologic findings were recovered 4 hours after treatment. When the acidosis was treated, the ECG abnormalities returned to normal (Figure 2 ). After the treatment was completed, 24 hour rhythm Holter ECG recording was normal. The patient was discharged from hospital without any sequel 2 days after admission. We observed that ajmaline challenge test was negative 2 weeks after the incident. She had no medication and arrhythmic syncope in the history. Her family members had neither pathological ECG findings nor history for sudden cardiac death. We have received confirmation from the family to be published. (6) presented a 16-year-old girl who took 2.4 g propafenone and had extreme QRS complex widening and prolonged PR interval on ECG. Brugada phenocopy was seen on ECG after saline infusion therapy, and she was discharged from hospital without any sequel. Metabolic conditions (hypokalaemia, hyperkalaemia, hyponatraemia, and hypercalcaemia), medicines with a sodium channel-blocking effect such as class 1 antiarrhythmic drugs, anaesthetics (especially propofol), tricyclic antidepressants, severe fever, or cocaine can cause Brugada phenocopy (1,3-7). Junttila et al. (7) evaluated 47 patients with a typical Brugadatype ECG due to medicines or severe fever in the emergency room. They detected malignant arrhythmias and sudden cardiac death in 51% and 37% of cases respectively. There is no specific treatment for propafenone intoxication. Haemodialysis or haemoperfusion can be used, but are frequently unsuccessful. Atropine, inotropic drugs, or pacemaker therapy may be required. As in our case, intravenous sodium bicarbonate infusion may support rapid and full recovery of dysrhythmia related to propafenone intoxication (3-7). If propafenoneinduced cardiotoxicity is unresponsive to the current treatment, intravenous lipid emulsion therapy or glucose-insulin infusion may be considered. In conclusion, Brugada phenocopy is the best term to define the Brugada type 1 ECG pattern without congenital Brugada syndrome. We presented a very rare case in children, propafenone intoxication which causes Brugada phenocopy. 
DISCUSSION

FIG. 2.
All electrocardiography abnormalities returned to normal 4 hours later.
